Literature DB >> 26311007

Successful acute and late management of a chemical burn with primary implantation of Boston type 1 keratoprosthesis.

Abhishek Ranjan1, Sirisha Senthil2, Virender Sangwan1.   

Abstract

A 29-year-old woman presented to our clinic 1 month after an accidental chemical burn with concentrated sulfuric acid, involving her entire face including eyes and neck. She received treatment for her ocular and facial burns, and subsequently underwent Boston type 1 keratoprosthesis in her right eye after 1 year. One week postoperatively, she was diagnosed with advanced disc damage, and was started on topical antiglaucoma medication. Visual field testing was only possible at 2 months postoperative, once visual acuity improved. Subsequently, progression of visual field defect was noted on Humphrey visual field 10-2, needing implantation of an Ahmed glaucoma valve in her right eye. Two years after the Boston type 1 keratoprosthesis implantation, the patient's best-corrected visual acuity was stable at 20/100; intraocular pressure was digitally normal with a stable visual field. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26311007      PMCID: PMC4551072          DOI: 10.1136/bcr-2014-209247

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.

Authors:  Fabiano Cade; Cynthia L Grosskreutz; Allyson Tauber; Claes H Dohlman
Journal:  Cornea       Date:  2011-12       Impact factor: 2.651

2.  Challenges in the implantation of a Boston type 1 keratoprosthesis and a glaucoma drainage device in a nanophthalmic eye.

Authors:  Sirisha Senthil; Kiranmaye Turaga; Ravi Kumar; Virender S Sangwan
Journal:  BMJ Case Rep       Date:  2014-10-01

3.  The anterior segments of rabbits after alkali burns. Metabolic and histologic alterations.

Authors:  R R Pfister; J Friend; C H Dohlman
Journal:  Arch Ophthalmol       Date:  1971-08

4.  Clinical outcomes of xeno-free allogeneic cultivated limbal epithelial transplantation for bilateral limbal stem cell deficiency.

Authors:  Sayan Basu; Mark M Fernandez; Sujata Das; Subhash Gaddipati; Geeta K Vemuganti; Virender S Sangwan
Journal:  Br J Ophthalmol       Date:  2012-09-13       Impact factor: 4.638

Review 5.  Evaluation and management of glaucoma after keratoprosthesis.

Authors:  Michael Banitt
Journal:  Curr Opin Ophthalmol       Date:  2011-03       Impact factor: 3.761

6.  Glaucoma associated with keratoprosthesis.

Authors:  P A Netland; H Terada; C H Dohlman
Journal:  Ophthalmology       Date:  1998-04       Impact factor: 12.079

7.  Glaucoma in patients with ocular chemical burns.

Authors:  Michelle P Lin; Ümit Ekşioğlu; Raghu C Mudumbai; Mark A Slabaugh; Philip P Chen
Journal:  Am J Ophthalmol       Date:  2012-05-24       Impact factor: 5.258

Review 8.  Glaucoma management in Boston keratoprosthesis type I recipients.

Authors:  Pho Nguyen; Vikas Chopra
Journal:  Curr Opin Ophthalmol       Date:  2014-03       Impact factor: 3.761

9.  Boston type 1 keratoprosthesis outcomes in ocular burns.

Authors:  Fernanda Pedreira Magalhães; Flavio Eduardo Hirai; Luciene Barbosa de Sousa; Lauro Augusto de Oliveira
Journal:  Acta Ophthalmol       Date:  2013-02-14       Impact factor: 3.761

10.  Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation.

Authors:  Delphine Rivier; Jayter S Paula; Eva Kim; Claes H Dohlman; Cynthia L Grosskreutz
Journal:  J Glaucoma       Date:  2009 Apr-May       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.